-
公开(公告)号:US07776867B2
公开(公告)日:2010-08-17
申请号:US11169312
申请日:2005-06-29
申请人: John Laird Buchanan , William H. Buckner , Simon A. Burkitt , Erin F. DiMauro , Christopher N. Farthing , Alexander D. Frenkel , Martin J. Harrison , Frank Kayser , Jinqian Liu , Sarah E. Lively , Teresa L. Marshall , David C. McGowan , Rajiv Sharma , Stephen J. Shuttleworth , Xiaotian Zhu
发明人: John Laird Buchanan , William H. Buckner , Simon A. Burkitt , Erin F. DiMauro , Christopher N. Farthing , Alexander D. Frenkel , Martin J. Harrison , Frank Kayser , Jinqian Liu , Sarah E. Lively , Teresa L. Marshall , David C. McGowan , Rajiv Sharma , Stephen J. Shuttleworth , Xiaotian Zhu
IPC分类号: C07D495/04 , C07D243/08 , C07D519/00 , A61K31/519 , A61K31/4995 , A61K31/496 , A61K31/427 , A61K31/5513 , A61K31/5377 , A61K31/538 , A61K31/541 , A61P35/00
CPC分类号: C07D491/04 , C07D495/04
摘要: The present invention relates to furanopyrimidine compounds having the general Formula I: and stereoisomers, tautomers, solvates, pharmaceutically acceptable salts and derivatives, and prodrugs thereof. The invention also includes pharmaceutical compositions comprising a compound of Formula I, methods of treating various diseases and conditions in a mammal, including inflammation, inhibition of T cell activation, proliferation, arthritis, organ transplant, ischemic or reperfusion injury, myocardial infarction, stroke, multiple sclerosis, inflammatory bowel disease, Crohn's disease, lupus, hypersensitivity, type 1 diabetes, psoriasis, dermatitis, Hashimoto's thyroiditis, Sjogren's syndrome, autoimmune hyperthyroidism, Addison's disease, autoimmune diseases, glomerulonephritis, allergic diseases, asthma, hayfever, eczema, cancer, colon carcinoma and thymoma, comprising administering to the mammal a therapeutically effective amount of a compound of Formula I. The invention also relates to methods of manufacturing medicaments, which comprise one or more compounds of Formula I.
摘要翻译: 本发明涉及具有通式I的呋喃并嘧啶化合物及其立体异构体,互变异构体,溶剂合物,药用盐和衍生物及其前药。 本发明还包括药物组合物,其包含式I化合物,治疗哺乳动物各种疾病和病症的方法,包括炎症,抑制T细胞活化,增殖,关节炎,器官移植,缺血或再灌注损伤,心肌梗塞,中风, 多发性硬化,炎性肠病,克罗恩病,狼疮,超敏反应,1型糖尿病,牛皮癣,皮炎,桥本氏甲状腺炎,干燥综合征,自身免疫性甲状腺功能亢进,艾迪生病,自身免疫性疾病,肾小球性肾炎,过敏性疾病,哮喘,干草病,湿疹, 结肠癌和胸腺瘤,包括向哺乳动物施用治疗有效量的式I化合物。本发明还涉及制备药物的方法,其包含一种或多种式I化合物。